Hanover, Germany

Andreas Fuchs


Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Darmstadt, DE (1985)
  • Hanover, DE (1987 - 1988)

Company Filing History:


Years Active: 1985-1988

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andreas Fuchs

Introduction

Andreas Fuchs is a notable inventor based in Hanover, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 4 patents to his name, Fuchs has focused on developing compounds that have important applications in medicine.

Latest Patents

Fuchs' latest patents include groundbreaking work on tetraoxo compounds and pharmaceutical compositions. One of his notable inventions involves tetraoxo compounds of the Formula (I), where R¹ is an alkyl, alkenyl, phenylalkyl, or cycloalkylalkyl group. Additionally, he has developed new pyridine derivatives, specifically certain di-aryl-1,2,3,6-tetrahydro-pyridyl-n-lower-alkylene-pyridines. These compounds, characterized by their unique structures, exhibit suppressant actions on the central nervous system, particularly neuroleptic actions.

Career Highlights

Throughout his career, Andreas Fuchs has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Patent Gesellschaft mit beschränkter Haftung and Kali-Chemie Pharma GmbH. His work in these organizations has allowed him to contribute to the advancement of pharmaceutical sciences.

Collaborations

Fuchs has collaborated with several professionals in his field, including Henning Bottcher and Christoph Seyfried. These collaborations have further enriched his research and development efforts.

Conclusion

Andreas Fuchs stands out as an influential inventor in the pharmaceutical sector, with a focus on innovative compounds that address critical health issues. His contributions continue to impact the field positively, showcasing the importance of research and development in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…